The immunopathology of human schistosomiasis-III: immunoglobulin isotype profiles and response to praziquantel

The immunopathology of human schistosomiasis-III: immunoglobulin isotype profiles and response to praziquantel

Immunoglobulin (Ig) isotype (IgG, IgG1, IgG2, IgG3, IgG4, IgM, IgD and IgE) levels were investigated, both pre- and post-treatment with praziquantel (PZQ), in 43 adults and children chronically infected with Schistosoma mansoni , by means of a two-site, isotype-specific immunoenzymometric assay. The...

Full description

Bibliographic Details
Main Authors:	Romelia M Ramírez, Evelia Ceballos, Belkisyolé Alarcón de Noya, Oscar Noya, Nicolás Bianco
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 1996-10-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	isotypes immunoglobulin Schistosoma mansoni praziquantel
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761996000500010

Similar Items

Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients Achados clínicos e no ultra-som pré e pós tratamento com praziquantel em pacientes venezuelanos com esquistossomose
by: Raiza Ruiz-Guevara, et al.
Published: (2007-10-01)

The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models
by: Érica Tex Paulino, et al.
Published: (2022-05-01)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
by: Eglal I. Amer, et al.
Published: (2022-03-01)

Efeito do praziquantel incorporado a lipossomas nos diferentes estágios de desenvolvimento dos ovos de Schistosoma mansoni
by: T.F. Frezza, et al.
Published: (2007-05-01)

Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
by: Muhubiri Kabuyaya, et al.
Published: (2018-07-01)

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
by: Maha M. Eissa, et al.
Published: (2020-09-01)

Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel
by: Patrícia Ivana Pires Bonesso-Sabadini, et al.
Published: (2002-04-01)

The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
by: Emily L. Webb, et al.
Published: (2021-09-01)

A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
by: Jean T. Coulibaly, et al.
Published: (2018-06-01)

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
by: Andrea Angeli, et al.
Published: (2022-12-01)

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni
by: Naglaa Mohamed El-Lakkany, et al.
Published: (2011-11-01)

Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet
by: L.A. Barros, et al.
Published: (2009-09-01)

Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?
by: Cuma Cumisa Ndamse, et al.
Published: (2022-03-01)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021-04-01)

Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
by: P. T. Hoekstra, et al.
Published: (2018-12-01)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
by: Amara RO, et al.
Published: (2018-08-01)

Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study
by: Poppy H.L. Lamberton, et al.
Published: (2017-06-01)

Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice Efeitos da quimioterapia nos estágios larvais do Schistosoma mansoni durante infecção e re-infecção de camundongos
by: Luciana M. Silva, et al.
Published: (2003-06-01)

Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes
by: Michael D. French, et al.
Published: (2015-10-01)

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries
by: Ye Shen, et al.
Published: (2017-09-01)

Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails
by: Flávia FB Couto, et al.
Published: (2011-03-01)

Schistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails
by: Helen Poole, et al.
Published: (2014-04-01)

Laboratory diagnosis of Schistosomiasis in areas of low transmission: a review of a line of research
by: O Noya, et al.
Published: (2002-10-01)

Evidence for functional ryanodine receptors in Schistosoma mansoni and their putative role in the control of calcium homeostasis
by: CLM Silva, et al.
Published: (1998-01-01)

Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni
by: Neusa Araújo, et al.
Published: (2008-08-01)

Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni
by: Neusa Araujo, et al.
Published: (2008-12-01)

Comparação entre praziquantel e oxamniquine no tratamento da esquistossomose mansoni
by: Antônio Emanuel, et al.
Published: (1983-06-01)

A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection
by: Amr Radwan, et al.
Published: (2019-06-01)

Schistosomiasis mansoni in areas of low transmission: epidemiological characterization of Venezuelan foci
by: Alarcón de Noya B, et al.
Published: (2002-01-01)

Efeito da quimioterapia sobre os ovos do Schistosoma mansoni Effect of chemotherapy on the Schistosoma mansoni eggs
by: Mitermayer Galvão dos Reis, et al.
Published: (1987-06-01)

Complementary effect of Capparis spinosa L. and silymarin with/without praziquantel on mice experimentally infected with Schistosoma mansoni
by: El-Hawary S. S., et al.
Published: (2018-03-01)

The effect of praziquantel in the angiogenic receptors, inflammation and inflammatory cytokines on the murine intestinal schistosomiasis
by: Emilia Barrios, et al.
Published: (2017-12-01)

Evolução das imunoglobunilas envolvidas na resposta imune de camundongos ao Schistosoma mansoni The evolution of immunoglobulins involved in the immune response to mice infected with Schistosoma mansoni
by: Othon de Carvalho Bastos, et al.
Published: (1984-04-01)

(Ca2+-Mg2+)ATPase in Schistosoma mansoni: evidence for heterogeneity and resistance to praziquantel
by: VMN Cunha, et al.
Published: (1998-01-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Persistent Urogenital Schistosomiasis and Its Associated Morbidity in Endemic Communities within Southern Ghana: Suspected Praziquantel<i> </i>Resistance or Reinfection?
by: Patience B. Tetteh-Quarcoo, et al.
Published: (2020-02-01)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
by: Jana Kovač, et al.
Published: (2017-08-01)

Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni
by: Leonardo C de Queiroz, et al.
Published: (2010-07-01)

Activity of praziquantel on in vitro transformed Schistosoma mansoni sporocysts
by: ACA Mattos, et al.
Published: (2006-10-01)

Comparação entre praziquantel e oxamniquine no tratamento da esquistossomose mansoni
by: Antônio Emanuel, et al.
Published: (1983-06-01)